Building a national headache medicine research network: The BE WELL with Migraine Champion Providers Network™.
Rebecca Erwin Wells, Junelyn Floyd, Hannah O'Brien...
https://pubmed.ncbi.nlm.nih.gov/41065019/Actively Recruiting
Led by Wake Forest University Health Sciences · Updated on 2026-06-12
286
Participants Needed
3
Research Sites
26 weeks
Total Duration
Researchers are evaluating two different virtual, non-drug treatment options designed to improve the lives of adults with migraine. This randomized clinical trial focuses on behavioral interventions delivered through online group sessions and an accompanying online platform. The study aims to understand how these approaches may help manage migraine symptoms and related disability, while participants continue their usual medications. Participants receive either of two behavioral programs, each consisting of 8 weekly virtual group sessions led by an instructor, supported by an online platform with additional learning materials. The study is fully virtual, with no in-person visits required. Pregnant women up to 16 weeks gestation are eligible, and participants must complete technology onboarding to use the platform. During the study, participants complete an initial online screening, followed by a phone or video call to complete baseline assessments and learn to use the platform. They keep daily headache logs online and complete several surveys measuring migraine disability, depression, anxiety, pain catastrophizing, and quality of life at multiple points up to 32 weeks. This process helps researchers measure changes from baseline to immediately after the 8-week intervention and during longer follow-up periods.
CONDITIONS
BE WELL With Migraine: Brain Education and WELLness With Migraine
N
Nicole Tamol
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Wake Forest University Health Sciences
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Group A: Weekly Virtual Behavioral Program (Format A) | Group B: Weekly Virtual Behavioral Program (Format B) |
|---|---|---|
| What it is | BE WELL with Migraine Group A is a behavioral intervention involving 8 weekly instructor-led virtual group sessions plus additional learning and resources on an online platform. | BE WELL with Migraine Group B is a behavioral intervention also involving 8 weekly instructor-led virtual group sessions and access to an online platform with supplementary material. |
| Role in study | Randomized investigational arm receiving BE WELL with Migraine (Format A). | Randomized investigational arm receiving BE WELL with Migraine (Format B). |
| Primary use/purpose | Intended to help adults with migraine improve their headache-related disability, migraine symptoms, and well-being through structured group education and wellness activities. | Designed to support adults with migraine in reducing headache disability and enhancing quality of life through group-based education and virtual wellness strategies. |
| How it is given/performed | Delivered as 8 weekly virtual group sessions with an instructor, plus self-paced learning and wellness activities accessed via an online platform. | Participants attend 8 weekly instructor-led online group sessions and have access to additional materials through a digital platform. |
| Evidence status | Results for this specific group format of BE WELL with Migraine are not yet established; the intervention is being evaluated for its effect on migraine-related disability and well-being. | No published efficacy outcomes yet for this group assignment; its impact on migraine disability and symptoms is under investigation in the ongoing study. |
| Important limitations | The effectiveness of this specific group format for migraine management is not yet known, and it may not be equally effective for all patient subgroups. The virtual group format and technology requirements could limit accessibility for some individuals. | There is currently no published evidence regarding the outcomes for this group format. Accessibility or engagement with digital/virtual group sessions may not reflect standard migraine care. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Initial online screen and scheduled phone or video call for baseline assessment
Duration - 8 weeks
Participants attend 8 weekly virtual group sessions and use an online platform with additional content to support migraine management.
Weekly virtual sessions
Duration - Up to 24 weeks post-treatment
Participants complete online surveys and headache logs to measure migraine disability, depression, anxiety, and quality of life up to 32 weeks after treatment.
Periodic online surveys and headache logs
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Rebecca Erwin Wells, Junelyn Floyd, Hannah O'Brien...
https://pubmed.ncbi.nlm.nih.gov/41065019/Wake Forest University Health Sciences
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborating Sponsor